Details for New Drug Application (NDA): 087750
✉ Email this page to a colleague
NDA 087750 describes VIRILON, which is a drug marketed by Chartwell and is included in one NDA. Additional details are available on the VIRILON profile page.
The generic ingredient in VIRILON is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
The generic ingredient in VIRILON is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
Summary for 087750
| Tradename: | VIRILON |
| Applicant: | Chartwell |
| Ingredient: | methyltestosterone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087750
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Nov 24, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
